IP Library Assignment 040059/0222
Patent Assignment
Reel/Frame 040059/0222

Notice of Grant of Security Interest in Patents

Recorded: 2016-09-16 Pages: 9
Assignor
STRATATECH CORPORATION
Executed: 2016-09-16
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
60 WALL STREET, NEW YORK, NEW YORK, 10005
Covered Properties (27)
Skin Substitutes with Improved Barrier Function
Patent: 6,974,697 →
Application: 10/087,346 →
Publication: US 2002/0168768
Skin Substitutes for Irritancy Testing
Patent: 7,501,238 →
Application: 10/087,388 →
Publication: US 2002/0187498
Skin Substitutes and Uses Thereof
Patent: 6,846,675 →
Application: 10/087,641 →
Publication: US 2002/0164793
Keratinocytes Expressing Exogenous Angiogenic Growth Factors
Patent: 7,498,167 →
Application: 10/425,784 →
Publication: US 2004/0009591
Species Specific Dna Detection
Patent: 7,462,448 →
Application: 10/633,141 →
Publication: US 2004/0146881
Organotypically Cultured Skin Tissue Comprising Niks Cells That Express Exogenous Hif-1A
Patent: 7,807,148 →
Application: 10/848,646 →
Publication: US 2005/0013807
Human Skin Equivalents Expressing Exogenous Polypeptides
Patent: 7,674,291 →
Application: 10/909,119 →
Publication: US 2005/0079578
Skin Substitutes and Uses Thereof
Patent: 7,541,188 →
Application: 11/006,014 →
Publication: US 2005/0226853
Skin Substitutes with Improved Barrier Function
Patent: 7,407,805 →
Application: 11/235,814 →
Publication: US 2006/0121608
Methods and compositions for selecting cells with increased potency
Patent: 9,216,202 →
Application: 11/297,916 →
Publication: US 2006/0222635
Human skin equivalents expressing exogenous polypeptides
Patent: 9,163,076 →
Application: 11/365,357 →
Publication: US 2006/0257383
Skin substitutes with improved purity
Patent: 9,295,543 →
Application: 11/375,950 →
Publication: US 2006/0258001
Skin Substitutes with Improved Barrier Function
Patent: 7,955,790 →
Application: 12/174,319 →
Publication: US 2010/0099576
Cold Storage of Organotypically Cultured Skin Equivalents for Clinical Applications
Application: 12/271,455 →
Publication: US 2009/0145087
Kit for Species Specific Dna Detection
Patent: 7,888,496 →
Application: 12/329,151 →
Publication: US 2009/0176299
Keratinocytes Expressing Exogenous Angiogenic Growth Factors
Patent: 7,915,042 →
Application: 12/392,221 →
Publication: US 2009/0169528
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 8,580,314 →
Application: 12/612,284 →
Publication: US 2010/0119615
Human Skin Equivalents Expressing Exogenous Polypeptides
Patent: 8,092,531 →
Application: 12/690,160 →
Publication: US 2010/0119495
Human Skin Substitutes Expressing Il-12
Application: 12/784,699 →
Publication: US 2010/0330046
Method of Treatment Using Organotypically Cultured Skin Tissue Comprising Niks Cells That Express Exogenous Hif-1A
Patent: 7,988,959 →
Application: 12/886,976 →
Publication: US 2011/0059057
Method of Treatment Using Organotypically Cultured Skin Tissue Comprising Niks Cells That Express Exogenous Hif-1A
Patent: 8,808,685 →
Application: 13/195,614 →
Publication: US 2011/0286985
Human Skin Equivalents Expressing Exogenous Polypeptides
Patent: 8,790,636 →
Application: 13/343,314 →
Publication: US 2012/0107283
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 8,685,463 →
Application: 14/054,445 →
Publication: US 2014/0067064
Cryopreservation of Viable Human Skin Substitutes
Application: 14/208,439 →
Publication: US 2014/0271583
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 8,992,997 →
Application: 14/220,320 →
Publication: US 2014/0288165
Human Skin Equivalents Expressing Exogenous Polypeptides
Patent: 9,526,748 →
Application: 14/335,534 →
Publication: US 2014/0335064
Dried and Irradiated Skin Equivalents for Ready Use
Patent: 9,526,811 →
Application: 14/669,095 →
Publication: US 2015/0196686
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913 Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Patent Security Interests Recorded at Reel 040059, Frame 0222 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0083 →
Security Interest Aug 1, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 071913/0691 →
Release of Security Interest Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →
Security Interest Oct 28, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 072700/0001 →